The Patient Advocate Foundation (PAF), a national non-profit has announced that it has received a substantial contribution which will provide additional funding support for prostate cancer patients through its Co-Pay Relief Program (CPR).

PAF’s Co-Pay Relief Program provides direct financial support for pharmaceutical co-payments to insured patients, including Medicare Part D beneficiaries, in 20 disease categories. Since the program’s inception in April 2004, CPR has distributed more than $77,650,000.00 million in assistance to over 36,000 men. In the last year, several internal enhancements have been made to the Co-Pay Relief Program to improve access including raising federal poverty (FPL) guidelines from 250% to 500% and creating 24-hour provider application portal.

“We are thrilled to announce additional funding for prostate cancer patients, which will allow us to offer financial assistance to hundreds of additional patients each year. The program is designed to improving the quality of life of men facing medical and financial hardship.

Nancy Davenport-Ennis, Founder and CEO of PAF sa